Cargando…

Multifocal cardiovascular calcification in patients with established cardiovascular disease; prevalence, risk factors, and relation with recurrent cardiovascular disease

AIMS: The aim is to investigate (multifocal) cardiovascular calcification in patients with established cardiovascular disease (CVD), regarding prevalence, risk factors, and relation with recurrent CVD or vascular interventions. Coronary artery calcification (CAC), thoracic aortic calcification (TAC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	van 't Klooster, Cilie C., Nathoe, Hendrik M., Hjortnaes, J., Bots, Michiel L., Isgum, Ivana, Lessmann, Nikolas, van der Graaf, Yolanda, Leiner, Tim, Visseren, Frank L.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082515/ https://www.ncbi.nlm.nih.gov/pubmed/32211511 http://dx.doi.org/10.1016/j.ijcha.2020.100499

Ejemplares similares

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2021)

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study
por: van’t Klooster, Cilie C, et al.
Publicado: (2019)

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2020)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study
por: Selvarajah, Sharmini, et al.
Publicado: (2011)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease
por: Groenland, Eline H., et al.
Publicado: (2022)

Impact of Cardiovascular Calcifications on the Detrimental Effect of Continued Smoking on Cardiovascular Risk in Male Lung Cancer Screening Participants
por: Jairam, Pushpa M., et al.
Publicado: (2013)

Bragatston study protocol: a multicentre cohort study on automated quantification of cardiovascular calcifications on radiotherapy planning CT scans for cardiovascular risk prediction in patients with breast cancer
por: Emaus, Marleen J, et al.
Publicado: (2019)

Cardiovascular disease prediction: do pulmonary disease-related chest CT features have added value?
por: Jairam, Pushpa M., et al.
Publicado: (2015)

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
por: Verhagen, Sandra N, et al.
Publicado: (2011)

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease
por: Smidt, Lisanne C. A., et al.
Publicado: (2021)

Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study
por: Holthuis, Emily I., et al.
Publicado: (2021)

Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease
por: Kranendonk, Mariëtte EG, et al.
Publicado: (2014)

Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data
por: Groenhof, T Katrien J, et al.
Publicado: (2020)

Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population
por: Willemink, Martin J., et al.
Publicado: (2015)

Learning coronary artery calcium scoring in coronary CTA from non-contrast CT using unsupervised domain adaptation
por: Zhai, Zhiwei, et al.
Publicado: (2022)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Machine learning in cardiovascular magnetic resonance: basic concepts and applications
por: Leiner, Tim, et al.
Publicado: (2019)

Evaluating a cardiovascular disease risk management care continuum within a learning healthcare system: a prospective cohort study
por: Groenhof, T Katrien J, et al.
Publicado: (2020)

Notch Signaling in Cardiovascular Disease and Calcification
por: Rusanescu, Gabriel, et al.
Publicado: (2008)

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016)

The association of incidentally detected heart valve calcification with future cardiovascular events
por: Gondrie, Martijn J. A., et al.
Publicado: (2010)

Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care
por: de Beus, Esther, et al.
Publicado: (2017)

Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease
por: Hutcheson, Joshua D., et al.
Publicado: (2023)

Imaging Cardiovascular Calcification
por: Wang, Ying, et al.
Publicado: (2018)

Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands
por: Castelijns, Maria C, et al.
Publicado: (2023)

Coronary artery calcifications on breast cancer radiotherapy planning CT scans and cardiovascular risk: What do patients want to know?
por: Gal, Roxanne, et al.
Publicado: (2021)

Cardiovascular Calcification in Chronic Kidney Disease—Therapeutic Opportunities
por: Himmelsbach, Anika, et al.
Publicado: (2020)

Automatic determination of cardiovascular risk by CT attenuation correction maps in Rb-82 PET/CT
por: Išgum, Ivana, et al.
Publicado: (2017)

The association between a genetic variant in the SULF2 gene, metabolic parameters and vascular disease in patients at high cardiovascular risk
por: Heidemann, Britt E, et al.
Publicado: (2023)

Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when
por: Groenhof, T Katrien J, et al.
Publicado: (2017)

Biomolecules Orchestrating Cardiovascular Calcification
por: Tintut, Yin, et al.
Publicado: (2021)

Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification
por: Disthabanchong, Sinee
Publicado: (2018)

The effect of computerized decision support systems on cardiovascular risk factors: a systematic review and meta-analysis
por: Groenhof, T. Katrien J., et al.
Publicado: (2019)

Stepwise implementation of a cardiovascular risk management care program in primary care
por: Smits, Geert, et al.
Publicado: (2022)

Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease
por: Sena, Brena F., et al.
Publicado: (2018)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021)

Cell Phenotype Transitions in Cardiovascular Calcification
por: Hortells, Luis, et al.
Publicado: (2018)

Extracellular Vesicles As Mediators of Cardiovascular Calcification
por: Bakhshian Nik, Amirala, et al.
Publicado: (2017)

Emerging roles of fibroblasts in cardiovascular calcification
por: Li, Wudi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_02t70cvjeifsg75aitfvsgnmr2